Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Myeloproliferative Disorders × Exercise × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Motor Activity 194 Breast Neoplasms 107 Neoplasms 85 Prostatic Neoplasms 32 Fatigue 26 Obesity 21 Colorectal Neoplasms 18 Colonic Neoplasms 15 Lung Neoplasms 14 Polycystic Ovary Syndrome 13 Ovarian Neoplasms 12 Precursor Cell Lymphoblastic Leukemia-Lymphoma 11 Head and Neck Neoplasms 10 Rectal Neoplasms 9 Lymphoma 9 Lymphedema 9 Weight Loss 8 Multiple Myeloma 8 Leukemia 8 Hematologic Neoplasms 8 Cardiotoxicity 8 Pancreatic Neoplasms 7 Insulin Resistance 7 Carcinoma, Non-Small-Cell Lung 7 Cognitive Dysfunction 6 Brain Neoplasms 6 Stomach Neoplasms 4 Sarcopenia 4 Recurrence 4 Peripheral Nervous System Diseases 4

Interventions

Cyclophosphamide 69 fludarabine phosphate 62 Peripheral Blood Stem Cell Transplantation 47 Whole-Body Irradiation 44 Mycophenolic Acid 44 Tacrolimus 41 Busulfan 39 Antilymphocyte Serum 37 fludarabine 35 Cyclosporine 33 Filgrastim 28 Melphalan 25 Methotrexate 24 Radiotherapy 20 Methylprednisolone 17 Cytarabine 17 Sirolimus 14 Granulocyte Colony-Stimulating Factor 13 Cord Blood Stem Cell Transplantation 13 thymoglobulin 12 Flow Cytometry 12 Etoposide 12 Azacitidine 12 Alemtuzumab 12 Cyclosporins 11 Biopsy 9 ruxolitinib 8 Thiotepa 8 Specimen Handling 8 Psychiatric Rehabilitation 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07384039 2026-02-05

MPN-Exercise

Hannover Medical School

Phase NA Not yet recruiting

Myeloproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon ⚡